CATALOGO DEI PRODOTTI DELLA RICERCA

Bagante, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.605
EU - Europa 6.928
AS - Asia 5.292
SA - Sud America 819
AF - Africa 185
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 20.846
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.448
RU - Federazione Russa 2.466
SG - Singapore 2.123
CN - Cina 1.486
GB - Regno Unito 1.260
IT - Italia 983
BR - Brasile 626
DE - Germania 465
HK - Hong Kong 457
VN - Vietnam 440
IE - Irlanda 410
SE - Svezia 375
FR - Francia 374
FI - Finlandia 203
KR - Corea 185
UA - Ucraina 104
TR - Turchia 102
BD - Bangladesh 91
IN - India 90
AR - Argentina 78
CA - Canada 69
NG - Nigeria 58
NL - Olanda 58
MX - Messico 52
IQ - Iraq 47
PK - Pakistan 37
AT - Austria 36
ID - Indonesia 36
JP - Giappone 36
ES - Italia 31
PL - Polonia 30
MA - Marocco 28
EC - Ecuador 25
BE - Belgio 24
CO - Colombia 24
SA - Arabia Saudita 24
CL - Cile 22
ZA - Sudafrica 22
CZ - Repubblica Ceca 20
UZ - Uzbekistan 20
PH - Filippine 18
VE - Venezuela 17
CH - Svizzera 16
MY - Malesia 16
KE - Kenya 14
RO - Romania 13
TN - Tunisia 11
AZ - Azerbaigian 10
NP - Nepal 10
PE - Perù 10
EG - Egitto 9
TG - Togo 9
ET - Etiopia 8
LT - Lituania 8
AE - Emirati Arabi Uniti 7
EU - Europa 7
PY - Paraguay 7
DO - Repubblica Dominicana 6
JO - Giordania 6
KZ - Kazakistan 6
RS - Serbia 6
UY - Uruguay 6
AU - Australia 5
BJ - Benin 5
HR - Croazia 5
HU - Ungheria 5
IL - Israele 5
KG - Kirghizistan 5
PS - Palestinian Territory 5
SC - Seychelles 5
EE - Estonia 4
JM - Giamaica 4
LB - Libano 4
MD - Moldavia 4
NO - Norvegia 4
OM - Oman 4
SY - Repubblica araba siriana 4
AL - Albania 3
AO - Angola 3
BH - Bahrain 3
BO - Bolivia 3
CR - Costa Rica 3
DZ - Algeria 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
LV - Lettonia 3
PA - Panama 3
PR - Porto Rico 3
PT - Portogallo 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BB - Barbados 2
LU - Lussemburgo 2
MT - Malta 2
MU - Mauritius 2
MW - Malawi 2
NI - Nicaragua 2
Totale 20.816
Salva come PNG Salva come JPEG
Città #
Singapore 1.151
Southend 1.100
Ashburn 1.012
San Jose 864
Moscow 771
Chandler 704
Dallas 640
Hong Kong 452
Dublin 408
Jacksonville 403
The Dalles 335
Woodbridge 320
Beijing 305
Verona 304
Council Bluffs 243
Houston 166
Munich 161
Ann Arbor 160
Lawrence 150
Princeton 150
New York 141
Wilmington 136
Ho Chi Minh City 135
Los Angeles 115
Helsinki 111
Hanoi 106
Nanjing 95
Jinan 91
Columbus 82
Buffalo 77
Shenyang 68
Redondo Beach 66
Santa Clara 66
Milan 64
Tianjin 57
Abuja 55
São Paulo 54
Sindelfingen 46
Hebei 42
Rome 39
London 36
Ningbo 36
Frankfurt am Main 35
Tokyo 35
Nanchang 34
Seattle 34
Changsha 33
Redwood City 31
Guangzhou 30
Boardman 29
Norwalk 28
Orem 28
Stockholm 28
Zhengzhou 28
Turku 27
Falls Church 26
Taizhou 26
Warsaw 24
Hangzhou 23
Montreal 23
Nuremberg 23
Seoul 23
San Francisco 22
Brooklyn 21
Chennai 21
Haikou 21
Washington 21
Bologna 20
Brussels 20
Vienna 20
Atlanta 19
Chicago 18
Tashkent 18
Toronto 18
Brasília 17
Cambridge 17
Manchester 17
Poplar 17
Taiyuan 17
Da Nang 16
Jiaxing 16
Phoenix 16
Brno 15
Des Moines 15
Mexico City 15
Denver 14
Jakarta 14
Lahore 14
Amsterdam 13
Baghdad 13
Biên Hòa 13
Campinas 13
Dong Ket 13
Haiphong 13
Redmond 13
Shanghai 13
Zurich 13
Belo Horizonte 12
Lanzhou 12
Rio de Janeiro 12
Totale 12.697
Salva come PNG Salva come JPEG
Nome #
Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 537
'Recurrence of cholangiocarcinoma after surgical treatment: an analysis of modes of occurrence, risk factors, and results of treatment. 335
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 319
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 297
A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC) 264
Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer 253
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 228
Impact of age on short-term outcomes of liver surgery: Lessons learned in 10-years' experience in a tertiary referral hepato-pancreato-biliary center 224
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 223
development of two nomograms for predicting major adverse cardiac events and death in patients admitted to the emergency department with chest pain 216
Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. 207
Usefulness of contrast-enhanced intraoperative ultrasonography (CE-IOUS) in patients with colorectal liver metastases after preoperative chemotherapy. 205
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis 199
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence 197
Prognostic value of portal hypertension after surgical resection of HCC in cirrhotic patients 196
Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data 195
Pancreatic resections in patients who refuse blood transfusions. The application of a perioperative protocol for a true bloodless surgery 194
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 194
Patterns and prognostic significance of lymph-node dissection for surgical treatment of peri-hilar and intrahepatic cholangiocarcinoma 192
Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection 189
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 188
Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System 188
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 188
Hepatolithiasis-associated cholangiocarcinoma: results from a multi-institutional national database on a case series of 23 patients. 187
Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma 185
Cholangiocarcinoma risk factors and the potential role of aspirin 185
A multi-institutional analysis of elderly patients undergoing a liver resection for intrahepatic cholangiocarcinoma 182
The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma 182
The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke 175
A machine learning analysis of difficulty scoring systems for laparoscopic liver surgery 172
Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas 171
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 169
Liver Resection for Breast Cancer Liver Metastases A Cost-utility Analysis 168
Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma 167
What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes 164
Defining when to offer operative treatment for intrahepatic cholangiocarcinoma: A regret-based decision curves analysis 163
Complications after liver surgery: a benchmark analysis 163
Central Pancreatectomy: from Open to Minimally Invasive 159
Tu1730 A Clinical Score Predicting the Occurence of Liver-Related Complications Following Hepatectomy 157
Primary liver cancer: Prognostic factors and predictive response to therapy 157
Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma 157
Defining Post Hepatectomy Liver Insufficiency: Where do We stand? 155
A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver Metastases 155
Surgical Resection Versus Local Ablation for HCC on Cirrhosis: Results from a Propensity Case-Matched Study 153
Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic Cholangiocarcinoma: Prognostic Impact After Surgery 153
Integrating Clinical Data and Molecular Profiling of Hepato-Pancreato-Biliary Cancers: a Surgical-pathological Approach 152
Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer 151
Impact of adjuvant chemotherapy on survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis 150
Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme 148
Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification 147
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 146
Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes 145
Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy 142
Validation of a Nomogram to Predict the Risk of Perioperative Blood Transfusion for Liver Resection 139
Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma 139
Pancreaticoduodenectomy with venous resection and reconstruction: current surgical techniques and associated postoperative imaging findings 139
ASO Author Reflections: Re-resection of Positive Bile Duct Margin for Hilar Cholangiocarcinoma 139
Impact of Delta Hemoglobin on Provider Transfusion Practices and Post-operative Morbidity Among Patients Undergoing Liver and Pancreatic Surgery 135
Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis 135
A Comparison of Open and Minimally Invasive Surgery for Hepatic and Pancreatic Resections Among the Medicare Population 135
Role of inflammatory and immune-nutritional prognostic markers in patients undergoing surgical resection for biliary tract cancers 135
Postoperative Omental Infarct After Distal Pancreatectomy: Appearance, Etiology Management, and Review of Literature 133
Role of Lymph Node Dissection in Small (≤ 3 cm) Intrahepatic Cholangiocarcinoma 131
Use of Machine Learning for Prediction of Patient Risk of Postoperative Complications After Liver, Pancreatic, and Colorectal Surgery 131
The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma 130
Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation 129
A Machine-Based Approach to Preoperatively Identify Patients with the Most and Least Benefit Associated with Resection for Intrahepatic Cholangiocarcinoma: An International Multi-institutional Analysis of 1146 Patients 129
Minimally Invasive vs. Open Hepatectomy: a Comparative Analysis of the National Surgical Quality Improvement Program Database 125
Outcomes of vascular resection associated with curative intent hepatectomy for intrahepatic cholangiocarcinoma 123
Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study 121
ASO Author Reflections: Minimally Invasive Surgery for Hepatocellular Carcinoma in the Setting of Portal Vein Hypertension 121
Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes 120
Neuroendocrine liver metastasis: The chance to be cured after liver surgery 119
Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma 119
A Multi-Institutional International Analysis of Textbook Outcomes Among Patients Undergoing Curative-Intent Resection of Intrahepatic Cholangiocarcinoma 119
The Impact of Discharge Timing on Readmission Following Hepatopancreatobiliary Surgery: a Nationwide Readmission Database Analysis 118
Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients 118
Pancreatic Fistula and Delayed Gastric Emptying After Pancreatectomy: Where do We Stand? 117
Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer 116
A novel online prognostic tool to predict long-term survival after liver resection for intrahepatic cholangiocarcinoma: The "metro-ticket" paradigm 116
Synergistic Effects of Perioperative Complications on 30-Day Mortality Following Hepatopancreatic Surgery 115
Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival 115
The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study 114
The Impact of Dedicated Cancer Centers on Outcomes Among Medicare Beneficiaries Undergoing Liver and Pancreatic Cancer Surgery 114
Quality of life after treatment of neuroendocrine liver metastasis 114
Infectious complications after surgery for perihilar cholangiocarcinoma: A single Western center experience 113
Variation in Medicare Payments and Reimbursement Rates for Hepatopancreatic Surgery Based on Quality: Is There a Financial Incentive for High-Quality Hospitals? 113
Nomogram to predict perioperative blood transfusion for hepatopancreaticobiliary and colorectal surgery 112
Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment 112
Liver transplantation in patients with liver metastases from neuroendocrine tumors 112
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent 111
Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy 111
Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery 110
Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma 108
The Cost of Failure: Assessing the Cost-Effectiveness of Rescuing Patients from Major Complications After Liver Resection Using the National Inpatient Sample 108
Quality Versus Costs Related to Gastrointestinal Surgery: Disentangling the Value Proposition 108
Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis 103
Management and outcomes among patients with mixed hepatocholangiocellular carcinoma: A population-based analysis 103
Kidney Disease: Improving Global Outcomes Classification of Chronic Kidney Disease and Short-Term Outcomes of Patients Undergoing Liver Resection 102
Synergistic Impact of Alpha-Fetoprotein and Tumor Burden on Long-Term Outcomes Following Curative-Intent Resection of Hepatocellular Carcinoma 100
Totale 15.917
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.428
article - articoli 72.044
book - libri 0
conference - conferenze 2.866
curatela - curatele 0
other - altro 497
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.021
Totale 152.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 0 0 0 0 0 0 0 0 0 0 0 44
2021/2022917 106 165 25 63 28 32 24 75 40 31 43 285
2022/20232.317 181 231 241 359 171 609 26 124 261 20 66 28
2023/20241.129 54 93 105 103 159 195 43 112 6 51 140 68
2024/20253.337 185 217 112 560 213 177 166 201 447 224 277 558
2025/20269.447 691 377 673 1.291 2.089 658 977 544 982 682 183 300
Totale 21.057